Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday

U.S. stocks were slightly higher, with the Nasdaq Composite gaining around 10 points on Monday.

Shares of Surgery Partners, Inc. SGRY fell sharply during Monday’s session following weak quarterly sales.

Surgery Partners posted adjusted earnings of 44 cents per share, versus market estimates of 38 cents per share. The company’s quarterly sales came in at $735.40 million missing expectations of $741.40 million, according to data from Benzinga Pro.

Surgery Partners shares tumbled 7.8% to $30.43 on Monday.

Here are some other big stocks recording losses in today’s session.

• Intuitive Machines, Inc. LUNR dipped 25.1% to $7.18 after the company said its lunar lander may have tipped over upon landing on the moon.
• Nyxoah S.A. NYXH fell 11.3% to $15.29. Nyxoah is expected to release fourth quarter financial results on March 5, 2024.
• Jin Medical International Ltd. ZJYL fell 11.2% to $6.30.
• TransMedics Group, Inc. TMDX dipped 8.6% to $75.99. TransMedics Group is expected to release financial results for the fourth quarter after market close on Feb. 26, 2024.
• World Acceptance Corporation WRLD declined 7% to $120.71. World Acceptance recently reported better-than-expected third-quarter financial results.
• MacroGenics, Inc. MGNX fell 7% to $16.88.
• Kosmos Energy Ltd. KOS dipped 7% to $5.55. Kosmos Energy reported a fourth-quarter fiscal 2023 revenue decline of 10% year-over-year to $507.81 million, beating the consensus of $477.73 million.
• Orla Mining Ltd. ORLA fell 6.8% to $3.38.
• Insulet Corporation PODD fell 5.8% to $173.54 after Barclays maintained an Equal-Weight rating on the stock and lowered its price target from $214 to $213.
• Summit Therapeutics Inc. SMMT declined 5.6% to $4.38.
• Moderna, Inc. MRNA fell 4.3% to $92.36 after HSBC downgraded the stock from Hold to Reduce but raised its price target from $75 to $86.

Now Read This: Top 3 Defensive Stocks That May Collapse In February